-+ 0.00%
-+ 0.00%
-+ 0.00%

AKARI THERAPEUTICS REPORTS BREAKTHROUGH PRECLINICAL DATA DEMONSTRATING SYNERGISTIC ACTIVITY OF AKTX-101 WITH KRAS INHIBITION IN KRAS-MUTATED PANCREATIC CANCER MODELS

Reuters·05/21/2026 21:01:00

Please log in to view news